NetworkNewsWire
Editorial Coverage: With the rapid growth of the legal American
cannabis market, other cannabidiol (CBD)-based products are often
overlooked. In particular, hemp has the opportunity to reach
medical and nutritional customers that cannabis can’t, and
ChineseInvestors.com (CIIX) (CIIX
Profile) is tapping into that market. With the potential to
provide similar benefits without the same restrictions, hemp
products can be sold in markets such as China, where cannabis
remains illegal. It’s a part of the market that CBD industry
leaders such as Freedom Leaf, Inc. (FRLF) are also
catering to, with marketing and media products for hemp companies.
Medical Marijuana, Inc. (MJNA), America’s first
publicly traded cannabis company, is carrying its CBD business
beyond the United States and across the Americas, while CV
Sciences, Inc. (CVSI) combines scientific research with a
consumer products division to bring innovative CBD products to the
market. At the farming end of the supply chain, Terra Tech
Corp. (TRTC) provides advanced agricultural solutions and
new, better strains of cannabis for a growing market.
The Growing Cannabidiol Market
The market for legal marijuana is growing at an
ever-accelerating rate. Recent research by Arcview Market Research
and BDS Analytics indicates that sales in North America reached almost
$10 billion in 2017 and are expected to reach $24.5 billion by
2021 as more markets are created for both medical and
recreational use. But this is still a sector threatened by great
uncertainties and limitations. With no legal cannabis market in
many parts of the globe, and with the current U.S. administration
dominated by anti-marijuana conservatives, legal marijuana
represents the troubled part of a larger CBD market.
For companies looking to that wider market, hemp offers a
growing option for the CBD industry, one unfettered by many of the
restrictions limiting marijuana. A report by the Brightfield
Group shows that hemp is likely to become a billion-dollar
market in the next three years. Used like cannabis in medicinal and
nutritional products, it benefits from a high portion of online
purchases – nearly two-thirds of hemp sales happen online.
Hemp also has the potential to reach larger international
markets. The American-led war on drugs has encouraged an
international climate that’s hostile to cannabis sales, but in
which hemp products mostly remain legal.
Bringing Cannabidiol Products to China
One of the companies best set to make the most of this
opportunity is ChineseInvestors
(CIIX).
Founded in 1999, ChineseInvestors.com is a leading financial
information website for Chinese-speaking investors in both the
United States and China. Through its website, the company offers a
range of investor information and services, including real-time
market commentary, analysis and educational products. It also
provides support services for companies looking to get into the
Chinese market, including consulting for companies considering
going public, advertising services and public relations-related
support. With information in both English and Chinese language
character sets, it provides an accessible presentation for
investors looking at China both from the inside and the
outside.
This is built around the ChineseInvestors Method, a unique
integration of a disciplined investing process, web-based tools,
personalized instructions and support. In this way, CIIX helps
investors make informed investment decisions and helps them meet
their individualized financial goals. This includes a division
committed to cryptocurrencies (http://nnw.fm/3pwZV), producing daily videos to inform
Chinese investors about this ever-growing and unregulated sector of
the Chinese economy.
Its position at the intersection of American and Chinese markets
has put CIIX in a perfect position to explore the wider cannabidiol
market. Marijuana use is illegal in China, but CBD oils, including
hemp-based CBDs, are legal. CIIX is committed to developing and
distributing hemp-based products in hopes of helping people improve
their overall health, targeting epilepsy, Alzheimer’s disease,
cirrhosis of the liver and various other health conditions. With
nearly 10 million epilepsy patients in China, products that can
help these customers have the potential to become big sellers in a
growing market.
In December 2016, CIIX reached a wholesale agreement with a CBD
health brand. Off the back of this, it launched its new subsidiary
ChineseCBDoil.com. This website went live on Jan. 31, 2017,
providing the world’s first Chinese language online store for CBD
health products. It provides a variety of nutritional supplements
containing CBD, including soft gels, capsules and concentrates
available to Chinese-speaking customers worldwide.
Though the company has emphasized the health benefits of CBD
products, it is also leveraging its financial and marketing
expertise to sell hemp-infused skin care products in China.
Sales thus far have been so successful that the company is
spinning off its subsidiary — CBD Biotechnology and
ChineseHempOil.com, Inc. — with the intention of listing the new
company’s common stock on the OTCQB (http://nnw.fm/Mxi3e). The site offers a variety of
hemp oil products, including OptHemp Ultra Premium oil,
peppermint-flavored hemp oil in softgels and gummies, and the Gold
Plus line of premium hemp oil.
CIIX CEO Warren Wang expressed his confidence in this new
development, stating in a press release, "We are excited to
announce our intention to spin off CBD Biotechnology and
ChineseHempOil.com, Inc. as we believe the existing business lines
and the new acquisitions in China, secured by CEO Summer Yun, will
allow these entities to continue to grow in their respective
markets, while bringing new value to the Company's existing
shareholders.”
Growth and Challenges in America
The company’s hemp-based health products are available in the
United States and Canada. Wang aims to double the company’s revenue
and expand the business in 2018, with growth in North America as
well as China. One of the tools to achieve this is a Yelp-style app
for CBD customers. Approved for download by the Apple App Store, it
is the world’s first Chinese-language mobile cannabis navigation
application. The app carries an easily searchable database of
marijuana dispensaries and cannabis strains. Customers can use the
platform to review and discuss cannabis products, allowing them to
find the best recommendations and nearby locations for medical and
recreational cannabis. This will broaden the company’s reach and
raise its profile in the growing number of states where marijuana
is legally accessible.
CIIX is committed to further research into the use of hemp oil
and other CBD products. The company in investing in research and
design enterprises with the goal of developing CBD drugs to combat
epilepsy and Alzheimer’s disease. The application period for new
drugs of this type in China is two to four years, meaning that the
company will be able to bring products to market far more quickly
than in the United States. If this research pays off, then the
company will not only be providing new uses for products in a
growth sector of the economy, it will also be in position to launch
them in the largest customer market in the world.
Because CBD remains classified as a Schedule 1 drug under the
Controlled Substance Act administered in the United States by the
Drug Enforcement Administration, hemp sales are regarded as illegal
by the federal government despite the growing number of states
legalizing it under their authority. Schedule 1 drugs are
identified as substances with a high potential for abuse, no
currently accepted medical use in the United States and a lack of
safety protocols under medical supervision (http://nnw.fm/Nm4CO). This prohibition is being
challenged in court, and that challenge now has the backing of a
cross-party group of Congress members. The Congressional group’s
arguments to the court state that the DEA’s ruling on CBD was an
“abuse of DEA’s administrative procedure and rulemaking authority”
and contrary to the definition of hemp set down by legislators in
the 2014 Farm Bill (http://nnw.fm/Y2EPp). With such strong political
support, the hemp industry is optimistic that this case will result
in clarity and a lifting of the restrictions to permit easier
expansion of CBD-based sales for companies such as CIIX.
The Cannabis Industry Connection
The deep connection between hemp production and the wider
cannabis industry is shown by the work of companies such as
Freedom Leaf (FRLF). A leading media producer and
distributor in the cannabis and hemp industries, Freedom Leaf is a
trusted source of information in the sector. The company is
involved in mergers and acquisitions in the marijuana industry and
has a portfolio of news, print and digital multi-media verticals,
websites and web advertising, establishing it as a media outlet and
discussion forum for a growing group of industries. It also
provides services in branding, licensing and marketing these
products, positioning it to make the most of fast growth in this
sector.
One of the great pioneers of the cannabis sector in both North
and South America, Medical Marijuana, Inc. (MJNA)
is also involved in hemp. The first publicly traded cannabis
company in the United States, the company also is situated in
Brazil and Puerto Rico. This forward-looking company is exploring
the medical and nutritional potential of hemp.
CV Sciences (CVSI) is both a researcher into
CBD-based medicines and a producer of consumer food products based
on that research. It is tapping into a wide range of market sectors
through products such as its Purified Liquids products for vaping.
Its PlusCBD Oil is the top-selling brand of hemp-derived CBD oil
for consumers in the natural products industry.
On the agricultural side, Terra Tech (TRTC) is
a vertically integrated, cannabis-focused company committed to
cultivating and providing the highest quality medical cannabis. Its
research-led approach to cultivating and cross-breeding marijuana
strains leads to better products for treating a wide range of
ailments. Its greenhouse and hydroponic systems allow the safe,
efficient growth of cannabis and other plants in urban farming
facilities, expanding the options for production in the CBD
industry.
With the wider CBD industry growing, companies such as
ChineseInvestors.com are aiming to profit from the growing power of
hemp and its legal position in a disputed market.
For more information on ChineseInvestors.com, visit: ChineseInvestors.com (CIIX)
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content
distribution company that provides (1) access to a network of wire
services via NetworkWire to
reach all target markets, industries and demographics in the most
effective manner possible, (2) article and editorial syndication to
5,000+ news outlets (3), enhanced press release services to ensure
maximum impact, (4) social media distribution via the Investor
Brand Network (IBN) to nearly 2 million followers, (5) a full array
of corporate communications solutions, and (6) a total news
coverage solution with NNW Prime. As a
multifaceted organization with an extensive team of contributing
journalists and writers, NNW is uniquely positioned to best serve
private and public companies that desire to reach a wide audience
of investors, consumers, journalists and the general public. By
cutting through the overload of information in today’s market, NNW
brings its clients unparalleled visibility, recognition and brand
awareness. NNW is where news, content and information converge.
For more information, please visit https://www.NetworkNewsWire.com
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Please see full terms of use and disclaimers on the
NetworkNewsWire website applicable to all content provided by NNW,
wherever published or re-published: http://NNW.fm/Disclaimer
DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by NNW are
solely those of NNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable NNW for any investment
decisions by their readers or subscribers. NNW is a news
dissemination and financial marketing solutions provider and are
NOT registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, NNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and NNW undertakes no
obligation to update such statements.
Source:
NetworkNewsWire
Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Apr 2023 to Apr 2024
